Stockholm - Free Realtime Quote SEK

Pila Pharma AB (publ) (PILA.ST)

4.3900

-0.0100

(-0.23%)

As of 4:35:32 PM GMT+1. Market Open.

STMicro, Samsung, Colgate-Palmolive: Stocks in 30

Seana Smith and Brad Smith take a look at three trending stocks in focus on the Morning Brief. STMicroelectronics (STM) is reportedly considering cutting its workforce by 6%, according to reports from Bloomberg. Samsung (005930.KS) warns of slow artificial intelligence (AI) chip sales due to competition among chipmakers and US export controls. Colgate-Palmolive (CL) forecasts annual sales weakness after missing on fourth quarter revenue hit by soft demand in North America and Latin America. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Naomi Buchanan.

Yahoo Finance Video 28 minutes ago

SSNLF

STM

STMEF
Intel beats Q4 estimates, faces tough Q1 ahead

Computer processor maker Intel (INTC) exceeded fourth quarter expectations despite a third straight quarter of declining revenue. Intel also fell short on weak guidance for the first quarter due to seasonal weakness, macro uncertainty, and rising competition. Morning Brief hosts Brad Smith and Seana Smith break down the latest on Intel's quarterly results and future outlook. The company is currently led by two interim co-CEOs and faces challenges in its long-term turnaround plan, which may take years. Additionally, analysts highlight Intel's need for substantial investment, which could include $20 billion in gross capital investments for 2025, to improve production and staffing. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Josh Lynch

Yahoo Finance Video 50 minutes ago

INTC
Apple earnings top Wall Street forecasts while iPhone, China sales fall short

Apple reported its Q1 2025 earnings after the bell Thursday, beating on expectations, but falling short on iPhone sales.

Yahoo Finance 18 hours ago

AAPL

INTC
Apple quarterly revenue increases, even as China sales decline 11%

Apple's latest earnings were a mixed bag, with slipping iPhone sales countered by rising revenue. Reporting after the bell Thursday, the iPhone maker’s overall revenue in the first quarter of 2025 beat Wall Street expectations, with a 4% bump to $124.3 billion over the same time last year. Apple reported net income of $36.33 billion, up 7.1% from $33.92 billion in the same year-ago period. The increase came even as the company missed iPhone estimates, with an 11.1% sales drop in China knocking r

TechCrunch 14 hours ago

AAPL
Intel has already received $2.2B in federal grants for chip production

Semiconductor giant Intel Corporation has already received $2.2 billion in federal grants from the U.S. Department of Commerce through the U.S. CHIPS and Science Act, the company shared during its Thursday earnings call. Dave Zinsner, Intel's co-interim CEO, executive vice president, and CFO, said the Silicon Valley-based company received the first tranche of $1.1 billion in federal grants at the end of 2024 and an additional $1.1 billion in January 2025. These grants are based on reaching certa

TechCrunch 15 hours ago

INTC
Mag 7 diverging, Fed uncertainty and tariffs: Market Takeaways

While US stocks (^DJI, ^IXIC, ^GSPC) edged higher to close out Thursday's trading session, Magnificent Seven components continue to diverge as the Big Tech giants continue to report earnings. Yahoo Finance senior markets reporter Josh Schafer joins Asking for a Trend to talk about the trends in mega-cap tech earnings and the Federal Reserve's latest interest rate decision, and the uncertainty around tariffs, To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 17 hours ago

^DJI

GOOG

NVDA
Intel tops Q4 2024 estimates as it continues CEO search

Intel (INTC) released its fourth quarter earnings results after Thursday's market close, beating quarterly revenue estimates with a figure of $14.26 billion (against expectations for $13.81 billion) alongside adjusted earnings per share (EPS) of $0.13 (against expectations for $0.12). Market Domination Overtime's Julie Hyman and Josh Lipton, alongside Head of Citizens JMP Mark Lehmann, react to Intel's earnings results and guidance following the departure of CEO Pat Gelsinger in December 2024. Interim Co-CEOs David Zinsner and Michelle Johnston Holthaus have commented that they have no updates for the company's ongoing chief executive search. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 18 hours ago

INTC
S&P 500 Market Cap vs. Equal Weight: What's the difference?

The S&P 500 (^GSPC) offers two distinct versions — the traditional market cap-weighted index and the equal-weighted index (^SPXEW, ^SP500EW) — each serving different analytical purposes. But what's the key difference between these two approaches? Yahoo Finance Markets and Data Editor Jared Blikre examines these market indicators, explaining their unique weighting methods, how individual stock performance impacts each index differently, and why these distinctions matter for investors making informed market decisions. To watch more expert insights and analysis on the latest market action, check out more Wealth here. This post was written by Angel Smith

Yahoo Finance Video 22 hours ago

GOOG

^SPXEW

TSLA
Mobileye issues weak sales outlook ahead of Intel earnings

Mobileye (MBLY) stock is in focus after the autonomous driving company provided investors with a weaker-than-expected annual revenue outlook. Seana Smith and Josh Schafer take a closer look at the results on Catalysts just ahead of Intel's (INTC) earnings release due out after Thursday's market close. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Naomi Buchanan.

Yahoo Finance Video 23 hours ago

MBLY

INTC
Why ABBV Is Rallying Today

AbbVie (ABBV), a large drug maker, is jumping 8% after the company provided significantly higher-than-expected 2025 earnings per share guidance this morning. Additionally, the company’s Q4 revenue came in above analysts’ average estimate. A Look at AbbVie’s Guidance and Results ABBV provided 2025 EPS guidance, excluding certain items, of $12.12 to $12.32. Analysts’ average estimate […]

Insider Monkey 7 minutes ago

ABBV
The FDA approved a new non-opioid painkiller. Its maker's stock is rising

Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators.

Quartz 10 minutes ago

VRTX
Atlassian Reports Strong Q2 Results, Stock Surges 17%

Atlassian reported Q2 FY25 revenue of $1.24 billion, exceeding analysts' expectations.

GuruFocus.com 12 minutes ago

TEAM
AbbVie Surges 8% As Immunology Powerhouses Skyrizi And Rinvoq Continue To Dominate

AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq by $4 billion.

Investor's Business Daily 30 minutes ago

ABBV
Apple shares rise as rosy sales outlook suggests iPhone demand momentum

Investing.com - Shares in Apple (NASDAQ:AAPL) were higher in early U.S. trading on Friday, as an upbeat revenue outlook tempered some concerns over slipping quarterly sales of its all-important iPhone device.

Investing.com 33 minutes ago

AAPL
AbbVie Jumps After Q4 Earnings Beat, Skyrizi And Rinvoq Boom Offsets Humira Decline

AbbVie Inc. (NYSE:ABBV) shares are trading higher on Friday. The company reported fourth-quarter adjusted earnings per share of $2.16, beating the street view of $2.11. Quarterly sales of $15.102 billion, outpacing the analyst consensus estimate of $14.827 billion. Revenues soared 5.6% on a reported basis, or 6.1% on an operational basis. Global net revenues from the immunology portfolio were $7.294 billion, an increase of 5.3% on an operational basis. Humira net revenues decreased 48.7% on an o

Benzinga 43 minutes ago

ABBV
Intel's Q4 Beats Expectations, But Analysts Warn of Rocky 2025

Intel posts strong Q4 results but warns of challenges ahead as analysts lower price targets amid weak guidance

GuruFocus.com 43 minutes ago

INTC
Why WBA Is Plunging Today

Walgreens Boots Alliance (WBA) is tumbling 11% in early trading. The sharp downturn comes after the company announced yesterday that it was “suspending” its dividend. WBA’s Dividend Halt WBA disclosed yesterday after the market closed that it would stop paying its quarterly cash dividend. The company has provided a dividend for over 90 years. In […]

Insider Monkey 43 minutes ago

WBA
Apple Gains on Forecast Following Mixed Holiday-Quarter Results

(Bloomberg) -- Apple Inc. gave a reassuring revenue forecast for the current quarter, helping boost shares of the world’s most valuable company after its holiday results showed jarring declines for China and the iPhone.Most Read from BloombergHow the 2025 Catholic Jubilee Is Reshaping RomeManhattan’s Morning Commute Time Drops With New Congestion TollTrump Paves the Way to Deputize Local Police on ImmigrationHousing Aid Uncertain After Trump’s Spending Freeze MemoTrump's Federal Funding Pause Th

Bloomberg 44 minutes ago

AAPL
Q2 2025 Viavi Solutions Inc Earnings Call

Q2 2025 Viavi Solutions Inc Earnings Call

Thomson Reuters StreetEvents 45 minutes ago

VIAV
Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval

Vertex Pharmaceuticals' non-opioid painkiller received approval from the Food and Drug Administration.

Investopedia 47 minutes ago

VRTX

Performance Overview

Return	PILA.ST	OMX Stockholm 30 Index
YTD	+17.07%	+7.64%
1-Year	+185.06%	+12.85%
3-Year	-22.09%	+17.91%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Pila Pharma AB (publ) (PILA.ST)

Related News

STMicro, Samsung, Colgate-Palmolive: Stocks in 30

Intel beats Q4 estimates, faces tough Q1 ahead

Apple earnings top Wall Street forecasts while iPhone, China sales fall short

Apple quarterly revenue increases, even as China sales decline 11%

Intel has already received $2.2B in federal grants for chip production

Mag 7 diverging, Fed uncertainty and tariffs: Market Takeaways

Intel tops Q4 2024 estimates as it continues CEO search

S&P 500 Market Cap vs. Equal Weight: What's the difference?

Mobileye issues weak sales outlook ahead of Intel earnings

Why ABBV Is Rallying Today

The FDA approved a new non-opioid painkiller. Its maker's stock is rising

Atlassian Reports Strong Q2 Results, Stock Surges 17%

AbbVie Surges 8% As Immunology Powerhouses Skyrizi And Rinvoq Continue To Dominate

Apple shares rise as rosy sales outlook suggests iPhone demand momentum

AbbVie Jumps After Q4 Earnings Beat, Skyrizi And Rinvoq Boom Offsets Humira Decline

Intel's Q4 Beats Expectations, But Analysts Warn of Rocky 2025

Why WBA Is Plunging Today

Apple Gains on Forecast Following Mixed Holiday-Quarter Results

Q2 2025 Viavi Solutions Inc Earnings Call

Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval

Performance Overview